Company Financials
89bio, Inc. Financials
United States dollar
business
89bio, Inc. Company Profile
Main Stock Listing
NASDAQ: ETNB
Market Capitalization $813.7 Million as of Jan. 1, 2025
Market Cap History
Valuations Metrics as of May. 5, 2024
| Trailing PE | |
| Forward PE | -3.16 |
| Price to Sales TTM | $ |
| Price to Book MRQ | $1.44 |
| Enterprise to Revenue | |
| Enterprise to EBITDA | -1.46 |
Financial Reports as of Dec. 31, 2023
Financials
| Fiscal Year Ends | 2023-12-31 |
| Most Recent Quarter | 2023-12-31 |
| Profit Margin | 0.00% |
| Operating Margin | 0.00% |
| Return on Assets TTM | -23.83% |
| Return on Equity TTM | -41.33% |
Income Statement
| Revenue TTM | $0 |
| Revenue per Share TTM | $ |
| Quarterly Revenue Growth | % |
| Gross Profit TTM | $0 |
| EBITDA | $-151,154,000 |
| Net Income to Common TTM | $-142,188,992 |
| Diluted EPS TTM | $-2.00 |
| Quarterly Earnings Growth YoY | % |
Balance Sheet
| Total Cash MRQ | $578,870,016 |
| Total Cash per Share MRQ | $6.19 |
| Total Debt MRQ | $ |
| Total Debt to Equity MRQ | 5.06 |
| Current Ratio MRQ | 20.04 |
| Book Value per Share MRQ | $5.75 |
Cash Flow
| Operating Cash Flow TTM | $-129,186,000 |
| Levered Free Cash Flow TTM | $-82,547,752 |
ETNB Stock Info as of May. 5, 2024
Stock Statistics
| Shares Outstanding | 95,224,704 |
| Float Shares | 68,579,397 |
| Avg 10 Volume | 745,220 |
| Avg 30 Volume | None |
| Shares Short | 11,209,464 |
| Short Ratio | 10.51 |
| Short % of Shares | 15.64% |
| % Held by Insiders | 0.84% |
| % Held by Institutions | 105.93% |
Stock Price Summary
| Beta | 0.95 |
| Fifty Two Week Low | $6.58 |
| Fifty Two Week High | $22.93 |
| Fifty Two Week Change | -88.72% |
| Day 50 MA | $10.97 |
| Day 200 MA | $11.88 |
Dividends and Splits
| Forward Annual Dividend Rate | $ |
| Forward Annual Dividend Yield | % |
| Trailing Annual Dividend Rate | $0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Dividend Date | |
| Ex Dividend Date | |
| Last Split Factor | |
| Last Split Date |